The Chicago Entrepreneur

More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says

For the first time, some Medicare beneficiaries will be able to access Novo Nordisk’s Wegovy without having to shoulder the total monthly price tag.

Previous post Arthur Hayes says macro setup favours Bitcoin bulls as KangaMoon attracts investors
Next post ‘I racked up $45,000 in credit-card debt making home repairs’: Should I refinance my $1.5 million house or take out a personal loan to pay it off?